AR117462A1 - Vacuna contra norovirus, formulaciones y métodos - Google Patents
Vacuna contra norovirus, formulaciones y métodosInfo
- Publication number
- AR117462A1 AR117462A1 ARP190103785A ARP190103785A AR117462A1 AR 117462 A1 AR117462 A1 AR 117462A1 AR P190103785 A ARP190103785 A AR P190103785A AR P190103785 A ARP190103785 A AR P190103785A AR 117462 A1 AR117462 A1 AR 117462A1
- Authority
- AR
- Argentina
- Prior art keywords
- methods
- formulations
- vaccine against
- against norovirus
- norovirus
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241001263478 Norovirus Species 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16071—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862782733P | 2018-12-20 | 2018-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR117462A1 true AR117462A1 (es) | 2021-08-04 |
Family
ID=71101884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190103785A AR117462A1 (es) | 2018-12-20 | 2019-12-19 | Vacuna contra norovirus, formulaciones y métodos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220054621A1 (enExample) |
| EP (1) | EP3897712A4 (enExample) |
| JP (1) | JP2022514759A (enExample) |
| KR (1) | KR20210114941A (enExample) |
| CN (1) | CN113453711A (enExample) |
| AR (1) | AR117462A1 (enExample) |
| AU (1) | AU2019404430A1 (enExample) |
| BR (1) | BR112021012181A2 (enExample) |
| CA (1) | CA3123860A1 (enExample) |
| CO (1) | CO2021009379A2 (enExample) |
| IL (1) | IL284233A (enExample) |
| MX (1) | MX2021007502A (enExample) |
| SG (1) | SG11202106628YA (enExample) |
| WO (1) | WO2020132510A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201601660YA (en) | 2007-09-18 | 2016-04-28 | Takeda Vaccines Inc | Method of conferring a protective immune response to norovirus |
| EP3299030B1 (en) | 2011-07-11 | 2022-06-08 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
| EP4340874A1 (en) | 2021-05-21 | 2024-03-27 | Takeda Vaccines, Inc. | Solid composition, freeze-drying method and glass vial |
| JPWO2024202045A1 (enExample) * | 2023-03-31 | 2024-10-03 | ||
| WO2025076792A1 (en) * | 2023-10-12 | 2025-04-17 | Chengdu Kanghua Biological Product Co., Ltd. | Methods of preparing norovirus vaccine with low amounts of adjuvant |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006335256B2 (en) * | 2005-11-22 | 2012-10-18 | Novartis Vaccines And Diagnostics, Inc. | Norovirus and sapovirus antigens |
| SG10201601660YA (en) * | 2007-09-18 | 2016-04-28 | Takeda Vaccines Inc | Method of conferring a protective immune response to norovirus |
| KR101793161B1 (ko) * | 2008-08-08 | 2017-11-03 | 다케다 백신즈 인코포레이티드 | 강화된 교차 반응성을 가진 복합체 캡시드 아미노산 서열들을 포함하는 바이러스-유사 입자들 |
| US20110070260A1 (en) * | 2009-09-09 | 2011-03-24 | Baric Ralph S | Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use |
| CA2787666A1 (en) * | 2010-01-21 | 2011-07-28 | Ligocyte Pharmaceuticals, Inc. | Targeted heterologous antigen presentation on calicivirus virus-like particles |
| EP3299030B1 (en) * | 2011-07-11 | 2022-06-08 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
-
2019
- 2019-12-19 AR ARP190103785A patent/AR117462A1/es not_active Application Discontinuation
- 2019-12-20 CA CA3123860A patent/CA3123860A1/en active Pending
- 2019-12-20 CN CN201980092246.7A patent/CN113453711A/zh active Pending
- 2019-12-20 BR BR112021012181-1A patent/BR112021012181A2/pt unknown
- 2019-12-20 MX MX2021007502A patent/MX2021007502A/es unknown
- 2019-12-20 KR KR1020217020497A patent/KR20210114941A/ko not_active Withdrawn
- 2019-12-20 SG SG11202106628YA patent/SG11202106628YA/en unknown
- 2019-12-20 WO PCT/US2019/067961 patent/WO2020132510A1/en not_active Ceased
- 2019-12-20 JP JP2021535827A patent/JP2022514759A/ja active Pending
- 2019-12-20 US US17/416,810 patent/US20220054621A1/en active Pending
- 2019-12-20 AU AU2019404430A patent/AU2019404430A1/en active Pending
- 2019-12-20 EP EP19901048.9A patent/EP3897712A4/en active Pending
-
2021
- 2021-06-20 IL IL284233A patent/IL284233A/en unknown
- 2021-07-19 CO CONC2021/0009379A patent/CO2021009379A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20220054621A1 (en) | 2022-02-24 |
| EP3897712A1 (en) | 2021-10-27 |
| EP3897712A4 (en) | 2022-08-31 |
| AU2019404430A1 (en) | 2021-07-08 |
| CN113453711A (zh) | 2021-09-28 |
| KR20210114941A (ko) | 2021-09-24 |
| BR112021012181A2 (pt) | 2021-08-31 |
| SG11202106628YA (en) | 2021-07-29 |
| CA3123860A1 (en) | 2020-06-25 |
| WO2020132510A1 (en) | 2020-06-25 |
| IL284233A (en) | 2021-08-31 |
| JP2022514759A (ja) | 2022-02-15 |
| MX2021007502A (es) | 2021-10-13 |
| CO2021009379A2 (es) | 2021-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2021009379A2 (es) | Formulaciones y métodos de la vacuna contra el norovirus | |
| ECSP18001613A (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas | |
| BR112017001796A2 (pt) | composições de flagelina e seus usos | |
| CL2018000320A1 (es) | Coadyuvantes basados en aceite (divisional de solicitud 201600650) | |
| MX2018014573A (es) | Vacuna contra el virus del zika. | |
| MX395525B (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
| EP3668541A4 (en) | FORMULATIONS FOR PNEUMOCOCCAL CONJUGATE VACCINE | |
| PL3585803T3 (pl) | Formulacje skoniugowanych szczepionek przeciwko pneumokokom | |
| MX2018001755A (es) | Vacuna contra viruela para tratamiento del cancer. | |
| EP4218807A3 (en) | Zika virus vaccine | |
| CR20140175A (es) | Compuestos y métodos para mejorar las respuestas inmunitarias innatas | |
| AR089797A1 (es) | Vacunas contra clostridum difficile que comprenden toxinas recombinantes | |
| MX2022002106A (es) | Formulaciones de vacuna de vial unico. | |
| CL2015001111A1 (es) | Composición coadyuvante que comprende un hidrato de carbono unido al quitosano formando una base de schiff; formulación de vacuna que la comprende; método de elaboración; y uso de la vacuna. | |
| MX2020011712A (es) | Vacunas de nanoparticulas multivalentes contra la influenza. | |
| MX2017005687A (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| MX2018005825A (es) | Celulas inmunes modificadas y usos de las mismas. | |
| MX2019005102A (es) | Poxvirus quimericos sinteticos. | |
| MX2023012390A (es) | Vacunacion con particulas de replicon y adyuvante oleoso. | |
| MX2016016746A (es) | Composiciones de vacuna con adyuvante dual, preparacion y usos. | |
| DOP2018000209A (es) | Constructos de alfavirus vivo atenuado y métodos y usos de los mismos | |
| MX2017011322A (es) | Sistema de marcadores, en particular para antigenos subunitarios expresados por baculovirus. | |
| MX2018012230A (es) | Métodos para tratar enfermedades oculares. | |
| IL286254A (en) | Tlr4-tlr7 ligand formulations as vaccine adjuvants | |
| MX2021005910A (es) | Formulacion de proteina de alta concentracion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |